logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Showing 1 - 4 of 4 Items
Showing 1 - 4 of 4 Items
Sort By: Relevance
  • Newest to oldest
  • Oldest to newest
  • Relevance
Journal Article
|
Research

Target product profiles: tests for tuberculosis treatment monitoring and optimization

Gupta-Wright A, den Boon S, MacLean E, Cirillo DM, Cobelens F,  et al.
2023-11-01 • Bulletin of the World Health Organization
2023-11-01 • Bulletin of the World Health Organization
The World Health Organization has developed target product profiles containing minimum and optimum targets for key characteristics for tests for tuberculosis treatment monitoring and opt...
Journal Article
|
Review

Programmatic management of drug-resistant tuberculosis: an updated research agenda

Mitnick CD, Rodriguez CA, Hatton ML, Brigden G, Cobelens F,  et al.
2016-05-25 • PLOS One
2016-05-25 • PLOS One
INTRODUCTION
There are numerous challenges in delivering appropriate treatment for multidrug-resistant tuberculosis (MDR-TB) and the evidence base to guide those practices remains li...
Journal Article
|
Research

Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study

Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E,  et al.
2011-04-19 • Lancet
2011-04-19 • Lancet
BACKGROUND: The Xpert MTB/RIF test (Cepheid, Sunnyvale, CA, USA) can detect tuberculosis and its multidrug-resistant form with very high sensitivity and specificity in controlled studies...
Journal Article
|
Review

Translational Research for Tuberculosis Elimination: Priorities, Challenges, and Actions

Lienhardt C, Lonnroth K, Menzies D, Balasegaram M, Chakaya JM,  et al.
2016-03-02 • PLOS Medicine
2016-03-02 • PLOS Medicine
Christian Lienhardt and colleagues describe the research efforts needed to end the global tuberculosis epidemic by 2035.